According to J. Zhu et al. (2021) [34], in rats subjected to ischemia–reperfusion injury, ALA treatment significantly increased SOD activity while reducing levels of malondialdehyde, NADPH oxidase activity, O2•− production, Nox expression, inflammation, and apoptosis. Here, FMO5 is linked to ischemia.